Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02100774Completed

Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability

Role: collaborator

NCT03992313Not ApplicableCompleted

Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia

Role: collaborator

NCT03599219Not ApplicableCompleted

Platelet Dysfunction in Blood Donors

Role: collaborator

NCT04517773Unknown

"Patient Autonomie" in People With Cancer

Role: collaborator

All 4 trials loaded